Concepedia

Charles G. Caldwell

CG

35

Publications

1.5K

Citations

24

H-Index

1940

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Charles G. Caldwell is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

PharmacologyMedicineDrug DiscoveryBiochemistryNatural SciencesMedicinal ChemistryChemical BiologyOrganic ChemistryPharmacotherapyChemistry

Publications per year

1940–2015

35

Publications

35

Electrolytic Macrocyclizations: Scalable Synthesis of a Diazonamide‐Based Drug Development Candidate

Hui Ding, Patrick DeRoy, Christian Perreault et al. · Angewandte Chemie International Edition · 2015 · 134 citations

The di--butylsilylene protecting group for diols

Barry M. Trost, Charles G. Caldwell · Tetrahedron Letters · 1981 · 92 citations

Organic Chemistry, Main Group Chemistry, Chemistry +1

Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2

Thomas H. Scheuermann, Daniel Stroud, Christopher E. Sleet et al. · Journal of Medicinal Chemistry · 2015 · 87 citations · Full text

Molecular Biology, Hif-2 Antagonism, Redox Biology +24

Substituted 4,6-diaminoquinolines as inhibitors of C5a receptor binding

Thomas J. Lanza, Philippe L. Durette, Thomas E. Rollins et al. · Journal of Medicinal Chemistry · 1992 · 84 citations · Full text

Drug Target, Chemical Modification, Pharmacotherapy +16

Binding of 2-Aryl-4-(piperidin-1-yl)butanamines and 1,3,4-Trisubstituted Pyrrolidines to Human CCR5: A Molecular Modeling-Guided Mutagenesis Study of the Binding Pocket

Laurie A. Castonguay, Youmin Weng, William Adolfsen et al. · Biochemistry · 2003 · 78 citations

Combinatorial Chemistry, Drug Target, Human Ccr5 Receptor +19

Rows per page

1–5 of 35